Liver Diseases: all 2,094 studies
Page 11 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Lifestyle Modification for MAFLD Based on TTMStatus unknownNCT04871880Not applicable
- Effect of L-Citrulline Supplementation on NAFLD in Adolescents With ObesityCompletedNCT04871360Not applicable
- Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver ImpairmentStatus unknownNCT04863144
- TReatment for ImmUne Mediated PathopHysiologyActive, not recruitingNCT04862221Phase 2
- Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, EgyptStatus unknownNCT04861012Not applicable
- A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Hepatic ImpairmentCompletedNCT04859426Phase 1
- The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid TurnoverCompletedNCT04859322Not applicable
- Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver DiseaseCompletedNCT04857606Phase 1
- Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM ConstitutionCompletedNCT04853082Early Phase 1
- Effect of Fatty Liver Disease on Bone DensityStatus unknownNCT04850547
- A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )Active, not recruitingNCT04849728Phase 3
- Effect of Mediterranean Diet in Obese Adolescents With Nonalcoholic Fatty Liver DiseaseCompletedNCT04845373Not applicable
- A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795CompletedNCT04844450Phase 1
- Dairy Protien Rich Diet for NAFLD PatientsCompletedNCT04841915Not applicable
- Serum Selenium and Zinc Levels in Non-alcoholic Fatty Liver Disease PatientsCompletedNCT04834063
- To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.CompletedNCT04831944Phase 1
- Intraoperative Phlebotomies and Bleeding in Liver TransplantationCompletedNCT04826666
- Gut Microbiota in Chronic Noncommunicable DiseasesCompletedNCT04820556
- Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver EnzymesCompletedNCT04816682Phase 4
- Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)WithdrawnNCT04807478
- 19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)CompletedNCT04806607Not applicable
- Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk PatientsCompletedNCT04802954Not applicable
- Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic ImpairmentCompletedNCT04791553Phase 1
- Mortality, Morbidity and Risk Factors of Liver RetransplantationCompletedNCT04789213
- Probiotics in Pediatric Chronic CholestasisStatus unknownNCT04787419Phase 2/3
- Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic EncephalopathyCompletedNCT04787276Not applicable
- Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenStatus unknownNCT04783116Not applicable
- Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology ConsultationCompletedNCT04782050Not applicable
- Chronic Kidney Disease and Non-alcoholic Fatty Liver DiseasesCompletedNCT04779905
- Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver TransplantationCompletedNCT04778735Not applicable
- Antibody Response to COVID-19 Vaccines in Liver Disease PatientsCompletedNCT04775069Phase 4
- A Study to Evaluate Vaccines Against COVID-19 in the Real WorldWithdrawnNCT04775056
- Elastography in Chronic Liver Disease in ChildrenStatus unknownNCT04774601
- A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of SitravatinibCompletedNCT04772612Phase 1
- Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With GoutStatus unknownNCT04772352Phase 2
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver DiseaseTerminatedNCT04766476Phase 1
- Thrombin Generation in Liver Transplant SurgeryStatus unknownNCT04762550
- MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic OutcomesCompletedNCT04761900
- Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF MelanomaWithdrawnNCT04759846Phase 1
- Surufatinib Hepatic Impairment StudyCompletedNCT04755075Phase 1
- A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic ImpairmentCompletedNCT04752540Phase 1
- Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver BiopsiesCompletedNCT04751045Not applicable
- Pain Scores and Complications do Not Differ at Three Recovery Position After Liver BiopsyStatus unknownNCT04750031
- Comparison of Hypothermic Versus Normothermic Ex-vivo Preservation.Status unknownNCT04744389Not applicable
- Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver DiseaseCompletedNCT04736966Phase 1
- Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort StudyStatus unknownNCT04734496
- Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver TransplantationCompletedNCT04732689
- Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II TrialActive, not recruitingNCT04727307Phase 2
- S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT04718051Phase 4
- FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisStatus unknownNCT04710524Phase 2
- Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRIStatus unknownNCT04701567
- Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLDCompletedNCT04698486Not applicable
- Cigarette Smoking in Non-alcoholic SteatohepatitisCompletedNCT04688307Not applicable
- A Prospective Study of Application of Platelet Mapping in Chronic Liver Disease Complicated With ALI and/or AD in ChinaCompletedNCT04675125
- Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With FibroscanCompletedNCT04671186Not applicable
- Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsCompletedNCT04668664
- Heal-Me Personalized Online Nutrition and Exercise RoutinesCompletedNCT04666558Not applicable
- Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver DiseaseStatus unknownNCT04660409Not applicable
- Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsCompletedNCT04643795Phase 1
- Effect of Empagliflozin on Liver Fat in Non-diabetic PatientsCompletedNCT04642261Phase 4
- Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.CompletedNCT04640324Not applicable
- TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesStatus unknownNCT04640116Not applicable
- A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of OzanimodCompletedNCT04639115Phase 1
- Healthcare Transition of Adolescents With Chronic Health ConditionsStatus unknownNCT04631965
- Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular CarcinomaCompletedNCT04627012
- Quantitative MRI Imaging in Diffuse Liver DiseasesStatus unknownNCT04626492
- Combi-elastography Assessment of Chronic Liver Disease Multi-center StudyStatus unknownNCT04625166
- Etiopathogenesis of Anemia in Chronic Liver DiseaseStatus unknownNCT04622449
- Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver TransplantationCompletedNCT04618692Not applicable
- Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic SurgeryStatus unknownNCT04615091
- Liver Disease in Urea Cycle DisordersActive, not recruitingNCT04612764
- Use of EL-FIT App to Promote Physical ActivityCompletedNCT04604860Not applicable
- Early Vascular Ageing in the YOUthCompletedNCT04598685
- Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT04594954Not applicable
- Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.CompletedNCT04579874Not applicable
- Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty LiverCompletedNCT04575506Not applicable
- Micro RNA Levels in NAFLDStatus unknownNCT04574557
- Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic ImpairmentCompletedNCT04573582Phase 1
- The Role of Immune Semaphorins in NAFLDCompletedNCT04573543
- Supplements SMOF in TPN for Liver Transplantation RecipientsCompletedNCT04572373
- Bariatric Surgery and Fatty Liver DiseaseCompletedNCT04569396
- Cognitive Function of Alcoholic Compensated Liver CirrhosisCompletedNCT04557774
- Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASHCompletedNCT04555434Phase 1/2
- Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.Status unknownNCT04553796
- Social & Contextual Impact on Children Undergoing Liver TransplantationActive, not recruitingNCT04551742
- Noninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese PopulationCompletedNCT04551716
- Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)CompletedNCT04546360
- The Early Strength Training Program in Post-transplant Liver CasesCompletedNCT04546048Not applicable
- To Describe the Clinical, Endoscopic and Endoscopic Ultrasound Features of Non-bleeding and Bleeding Rectal Varices, Among Patients With Portal HypertensionStatus unknownNCT04535440
- A Diagnostic Study on Patients With Drug-induced Liver InjuryStatus unknownNCT04526548
- Ultrasound Quantification of Liver FatCompletedNCT04523584
- Functional Roll for Non-alcoholic Fatty Liver DiseaseCompletedNCT04520724Not applicable
- TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCCCompletedNCT04518852Phase 2
- CytoSorb in Patients With Liver FailureCompletedNCT04511507
- Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric SurgeryStatus unknownNCT04501042
- A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy ControlsStatus unknownNCT04494269Phase 1
- Screening for Alcohol-related Cognitive Impairments in Cirrhotic PatientsTerminatedNCT04490330
- A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic FunctionCompletedNCT04482270Phase 1
- Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University HospitalsStatus unknownNCT04482153
- Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic FunctionCompletedNCT04469920Phase 1